This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
Ex vivo lung perfusion-to-lung transplant rat survival model with reproducible development of acute lung injury and graft rejection.
JHLT open · 2025
Permissive immunosuppression facilitates the expansion of ex vivo administered regulatory T cells in the lung allograft.
Scientific reports · 2025
Detailed cellular and spatial characterization of chronic lung allograft dysfunction using imaging mass cytometry.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2025
Latest funding
- $484,151
Applying machine learning to 3D tumor histopathology for predicting patient outcomes
CIHR · 2019 · Co-investigator
- $2,100,092
Integrated Nanotechnology and Biomedical Sciences Laboratory
CIHR · 2017 · Co-investigator
- $632,425
Next-Generation Antimicrobial Diagnostics: Speed and Precision via Whole Genome Sequencing
NSERC · 2017 · Co-investigator
46 publications.
Ex vivo lung perfusion-to-lung transplant rat survival model with reproducible development of acute lung injury and graft rejection.
Miyamoto E, Ohsumi A, Hwang D, Boonstra K, Cypel M, Martinu T, Keshavjee S, Juvet SC
Permissive immunosuppression facilitates the expansion of ex vivo administered regulatory T cells in the lung allograft.
Takahagi A, Miyamoto E, Lam C, Liu M, Joe B, Wang X, Hwang D, Martinu T, Cypel M, Keshavjee S, Juvet S
Detailed cellular and spatial characterization of chronic lung allograft dysfunction using imaging mass cytometry.
Renaud-Picard B, Moshkelgosha S, Berra G, Cheung M, Hwang D, Hedley D, Juvet S, Martinu T
Local intragraft humoral immune responses in chronic lung allograft dysfunction.
Miyamoto E, Vosoughi D, Wang J, Al-Refaee J, Berra G, Daigneault T, Duong A, Joe B, Moshkelgosha S, Keshavjee S, Tinckam K, Hwang D, Chruscinski A, Juvet S, Martinu T
The CD8+ T cell content of transbronchial biopsies from patients with a first episode of clinically stable grade A1 cellular rejection is associated with future chronic lung allograft dysfunction.
Beber SA, Moshkelgosha S, White M, Zehong G, Cheung M, Hedley D, Levy L, Samuels J, Renaud-Picard B, Hwang D, Martinu T, Juvet S
Spectrum of chronic lung allograft dysfunction pathology in human lung transplantation.
Renaud-Picard B, Berra G, Hwang D, Huszti E, Miyamoto E, Berry GJ, Pal P, Juvet S, Keshavjee S, Martinu T
Therapeutic Effects of a Novel Aptamer on Coronaviral Infection-Induced Lung Injury and Systemic Inflammatory Responses.
Wang Y, Lindstam M, Hwang D, Jedlina L, Liu M
Center variability in the prognostic value of a cumulative acute cellular rejection "A-score" for long-term lung transplant outcomes.
Belousova N, Huszti E, Li Q, Vasileva A, Ghany R, Gabarin R, El Sanharawi M, Picard C, Hwang D, Levy L, Keshavjee S, Chow CW, Roux A, Martinu T
Programmed Cell Death Protein 1 Inhibitors and MET Targeted Therapies in NSCLC With MET Exon 14 Skipping Mutations: Efficacy and Toxicity as Sequential Therapies.
Lau SCM, Perdrizet K, Fung AS, Mata DGMM, Weiss J, Holzapfel N, Liu G, Bradbury PA, Shepherd FA, Sacher AG, Feilotter H, Sheffield B, Hwang D, Tsao MS, Cheng S, Cheema P, Leighl NB
Lung allograft standardized histological analysis (LASHA) template: A research consensus proposal.
Calabrese F, Roden AC, Pavlisko E, Lunardi F, Neil D, Adam B, Hwang D, Goddard M, Berry GJ, Ivanovic M, Thüsen JV, Gibault L, Lin CY, Wassilew K, Glass C, Westall G, Zeevi A, Levine DJ, Roux A
Applying machine learning to 3D tumor histopathology for predicting patient outcomes
Principal investigators: Chan, Warren C; Damaskinos, Savvas; Tsao, Ming-Sound
Keywords: Cancer; Imaging; Machine Learning
Integrated Nanotechnology and Biomedical Sciences Laboratory
Principal investigators: Chan, Warren C
Keywords: Cancer; Nanotechnology
Next-Generation Antimicrobial Diagnostics: Speed and Precision via Whole Genome Sequencing
Principal investigators: Guttman, David
Microbiota and the Immunomobiology of Lung Allograft Dysfunction (MI-LAD)
Principal investigators: Coburn, Bryan A; Martinu, Tereza
Keywords: Animal Model; Bacteriology; Chronic Lung Allograft Dysfyunction; Human Studies; Il-17; Immunology; Inflammation; Lung Transplantation; Microbiome; Rejection
Next-Generation Antimicrobial Diagnostics: Speed and Precision via Whole Genome Sequencing
Principal investigators: Guttman, David S; Coburn, Bryan A; Hwang, David M; Shapiro, Jesse
Keywords: Antibiotic Resistance; Diagnostic Testing; Genome Analysis; Genome-Wide Association Study; Human Health; Infectious Diseases; Microbiology; Predictive Modeling; Pseudomonas Aeruginosa
Nanotechnology-enabled image-guided interventions in vascular and lung diseases
Principal investigators: Zheng, Gang; Chan, Warren C; Wilson, Brian C
Keywords: Hdl-Mimicking Peptide-Lipid Nanoparticles; Image-Guided Interventions; Lung Cancer; Nanoparticles; Raman Active Phospholipid Gold Nanoparticles; Sers Imaging Endoscopy; Vascular Diseases
Assessing the breadth and depth of cystic fibrosis-associated polymicrobial respiratory tract infections
Principal investigators: Guttman, David S; Cowen, Leah E; Davidson, Alan R; Hwang, David M; O'Doherty, Kieran C; Parkinson, John; Tullis, Diana E; Waters, Valerie J; Yau, Yvonne C
Keywords: Antibiotic Resistance; Bacteria; Bacteriophage; Community Structure; Cystic Fibrosis; Fungi; Lung Infections; Metagenomics; Next-Generation Genomics; Population Dynamics
Assessing the breadth and depth of cystic fibrosis-associated polymicrobial respiratory tract infections
Principal investigators: Guttman, David S; Davidson, Alan R; Hwang, David M
Keywords: Bacteria; Bacteriophage; Cystic Fibrosis; Fungi; Longitudinal Study; Metagenomics
Assessing the impact of polymicrobial pulmonary infections in cystic fibrosis via metagenomics
Principal investigators: Hwang, David M; Guttman, David S
Keywords: Chronic Lung Disease; Cystic Fibrosis; Dna Sequencing; Metagenomics; Microbiome; Pulmonary Exacerbation
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Department of Surgery
- Oncology
- Cell and Systems Biology
- Thoracic Surgery
- Toronto General Research Institute
- Department of Medicine
- Department of Laboratory Medicine and Pathobiology
- Other
Co-authors at University of Toronto, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Shaf Keshavjee
Thoracic Surgery
15 shared papers, latest 2025
Marcelo Cypel
Thoracic Surgery
12 shared papers, latest 2025
Mingyao Liu
Department of Surgery
12 shared papers, latest 2025
Tereza Martinu
Toronto General Research Institute
11 shared papers, latest 2025
Stephen Juvet
Toronto General Research Institute
6 shared papers, latest 2025
Ming-Sound Tsao
Department of Laboratory Medicine and Pathobiology
4 shared papers, latest 2020
Kazuhiro Yasufuku
Department of Surgery
3 shared papers, latest 2020
David Hedley
Medical Oncology
2 shared papers, latest 2025
Andrzej Chruscinski
Faculty
1 shared papers, latest 2025
Armand Keating
Mechanical Engineering
1 shared papers, latest 2015
Thomas Waddell
Thoracic Surgery
1 shared papers, latest 2020
Lorenzo Del Sorbo
Faculty
1 shared papers, latest 2016
Shahid Husain
Department of Medicine
1 shared papers, latest 2020
Jonathan Yeung
Department of Surgery
1 shared papers, latest 2020
George Tomlinson
Biostatistics Division
1 shared papers, latest 2020
Kayvan Amjadi
Department of Medicine
1 shared papers, latest 2016
Jean-claude Cutz
Pathology & Molecular Medicine
1 shared papers, latest 2016
Chung-Wai Chow
Faculty
1 shared papers, latest 2024
John Goffin
Oncology
1 shared papers, latest 2016
Gang Zheng
Faculty
1 shared papers, latest 2016
Bryan Coburn
Cell and Systems Biology
1 shared papers, latest 2019
Serge Puksa
Medicine
1 shared papers, latest 2016
Geoffrey Liu
Epidemiology Division
1 shared papers, latest 2023
Peter Ellis
Oncology
1 shared papers, latest 2016
Giovanni Blandino
Oncology
1 shared papers, latest 2018
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.